GlassScriptPhysician profile
Malorie Lipman
NPI 1790216455
$1,564.98
in general payments reported to CMS, 2019-2025
20 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $36.55 · 2022: $412 · 2023: $401 · 2024: $397 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,026 · Education: $90.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,025.60 |
| Education | $90.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $444.24 | 2023-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $226.04 | 2022-2025 | |
| Hologic Sales and Service, LLC | $188.50 | 2023-2025 | Aptima, Thinprep 2000 Processor, Acessa Provu System |
| Abbvie INC. | $107.25 | 2021-2023 | |
| Exeltis, USA INC. | $104.75 | 2022-2023 | Slynd |
| Organon LLC | $96.37 | 2022-2025 | Nexplanon, Jada System |
| Baxter Healthcare | $61.44 | 2022-2024 | Tisseel |
| Myovant Sciences INC. | $50.55 | 2022 | |
| Millicent US INC | $42.52 | 2024-2025 | Intrarosa, Femring |
| Ascend Therapeutics US, LLC | $35.81 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $34.38 | 2024 | Keytruda |
| Avion Pharmaceuticals | $30.87 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $26.31 | 2025 | |
| Minerva Surgical, INC | $21.89 | 2022 | |
| Biogen, INC. | $21.80 | 2025 | Zurzuvae |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $16.55 | 2022 | |
| Mylan Pharmaceuticals INC. | $15.96 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.79 | 2023 | |
| Therapeuticsmd, INC. | $14.94 | 2022 | |
| Meditrina | $9.02 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Malorie Lipman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.